
Shoulder & Elbow
Leucocyte- and platelet-rich fibrin have no effect on outcomes of rotator cuff repair
This report has been verified
by one or more authors of the
original publication.
J Shoulder Elbow Surg. 2016 Jan;25(1):2-11
35 patients, over the age of 55 years, with chronic, full-thickness rotator cuff tears were randomized to receive arthroscopic rotator cuff repair alone (control) or with the application of autologous leucocyte- and platelet-rich fibrin (L-PRF). The purpose of this study was to determine if the augmentation of L-PRF to arthroscopic repair resulted in significant clinical and radiographic benefits when assessed after 1 year. The results displayed no significant differences between groups in terms of satisfaction, Constant-Murley scores, Subjective Shoulder Value, Simple Shoulder Test, VAS pain, and other clinical and radiographic outcomes, at 1 year.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.